Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study

N Buetti1, A Atkinson2, L Kottanattu2

  • 1Department of Infectious Diseases, University Hospital Bern, Freiburgstrasse 3010, Bern, Switzerland. niccolo.buetti@gmail.com.

Insights

Pediatric bloodstream infections in Switzerland are primarily caused by Staphylococcus aureus and Escherichia coli, with consistently low resistance rates. Coagulase-negative staphylococci (CoNS) bloodstream infections increased significantly, while pneumococcal infections decreased, likely due to vaccination.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Pediatrics
  • Antimicrobial Resistance

Background:

  • Pediatric bloodstream infections (BSIs) represent a significant global health concern.
  • Understanding regional pathogen distribution and antimicrobial resistance patterns is crucial for effective treatment and public health strategies.
  • Switzerland's specific epidemiological landscape for pediatric BSIs requires detailed characterization.

Purpose of the Study:

  • To characterize the epidemiology of pediatric bloodstream infections (BSIs) in Switzerland.
  • To analyze pathogen distribution and antimicrobial resistance patterns in pediatric BSIs from 2008 to 2014.
  • To compare pathogens and resistance trends across multiple acute care hospitals.

Main Methods:

  • Analysis of data from the Swiss Antibiotic Resistance Surveillance (ANRESIS) database.
  • Inclusion of 3,067 bacteremia episodes, with 1,823 confirmed as true BSIs.
  • Statistical analysis comparing pathogens and resistance patterns in monomicrobial and polymicrobial BSIs across 20 acute care hospitals.

Main Results:

  • Staphylococcus aureus (16.5%) and Escherichia coli (15.1%) were the most frequent pathogens.
  • Coagulase-negative staphylococci (CoNS) BSIs increased by 50% from 2008 to 2014 (p=0.03).
  • Streptococcus pneumoniae BSIs decreased significantly (p=0.007), coinciding with the introduction of the 13-valent conjugate vaccine.

Conclusions:

  • Staphylococcus aureus and Escherichia coli remain the dominant pathogens in Swiss pediatric BSIs, with low resistance rates.
  • A notable increase in CoNS BSIs was observed over the study period.
  • The decline in S. pneumoniae BSIs is likely attributable to widespread pneumococcal conjugate vaccination.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
346
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
411
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
13.8K